US 2017/0281620 A1Published application

Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity

AssigneeParion Sciences, Inc.

InventorMichael Ross JOHNSON

Life of this patent

Estimating the term…

Abstract

A very stable, selective and renally safe sodium channel blocker represented by the formula: The invention also includes a variety of compositions, combinations and methods of treatment using this inventive sodium channel blocker.

Claims5

Dependent claims

1-23. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 15/485,361Filed 12 Apr 2017
Priority: 27 Jun 2011
Published: 5 Oct 2017
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 31/4965
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: non-condensed pyrazines
A61K 31/495
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with two or more nitrogen atoms as the only ring…
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 7/00
Drugs for disorders of the blood or the extracellular fluid

Family

Application61/501,524Us provisional application · filed 27 Jun 2011
Application14/129,734Continuation · filed 3 Jan 2014
Application14/594,744Continuation · filed 12 Jan 2015
Application15/485,361Continuation
US 2014/0142118 A1Published application
US 2015/0290189 A1Published application
US 9,072,738 B2Related patent
US 9,655,896 B2Related patent
US 2017/0281620 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results